Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis

Cindy M. Liu, Katerina Soldanova, Lora Nordstrom, Michael G. Dwan, Owain L. Moss, Tania L. Contente-Cuomo, Paul Keim, Lance B. Price, Andrew P. Lane

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

Background: Chronic rhinosinusitis (CRS) is a highly prevalent and heterogeneous condition frequently treated with antibiotics and corticosteroid therapy. However, the effect of medical therapy on sinus microbiota remains unknown. Methods: We enrolled CRS patients (n = 6) with patent maxillary antrostomies and active mucosal inflammation, who had not received antibiotics or corticosteroids in the previous 8 weeks. A pretreatment and posttreatment maxillary sinus swab was collected, from which DNA was extracted, pyrosequenced, and analyzed using a naïve Bayesian classifier and ecological analyses. Results: Four patients showed significant improvement in endoscopic appearance. The shifts in microbiota in response to therapy were highly individualized. There was no single common microbiota profile among patients with similar clinical outcomes, but overall there was significant decrease in microbiota diversity (t(5) = 2.05, p = 0.10) and evenness (t(5) = 2.28, p = 0.07) after treatment. Conclusion: Our findings strongly correlate with earlier studies that examined the impact of antibiotics on human microbiota. We observed that posttreatment, patients frequently became colonized by taxa that are less susceptible to the prescribed antibiotics. Our findings highlight the challenge in seeking generalizable diagnostic and therapeutic options in CRS, particularly regarding microbiological response and outcomes.

Original languageEnglish (US)
Pages (from-to)775-781
Number of pages7
JournalInternational Forum of Allergy and Rhinology
Volume3
Issue number10
DOIs
StatePublished - Oct 2013

Keywords

  • 16S rRNA gene
  • Chronic rhinosinusitis
  • Maximum medical therapy
  • Microbiology
  • Microbiome
  • Microbiota
  • Nasal polyposis
  • Sinusitis, eosinophilic rhinitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis'. Together they form a unique fingerprint.

  • Cite this

    Liu, C. M., Soldanova, K., Nordstrom, L., Dwan, M. G., Moss, O. L., Contente-Cuomo, T. L., Keim, P., Price, L. B., & Lane, A. P. (2013). Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. International Forum of Allergy and Rhinology, 3(10), 775-781. https://doi.org/10.1002/alr.21195